Capital Flow Monitor · Sponsors · CIK 1683553
SPRUCE BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080 · (415) 655-4168
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$50.0M
Sold
$50.0M
% sold
100.0%
Investors
21
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-17 | D ·current | 506(b) | $50.0M | $50.0M | 100.0% | 21 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Javier Szwarcberg — Executive Officer / Director, South San Francisco, CA
-
Bali Muralidhar — Director, South San Francisco, CA
2 other raises
- Allotera Therapeutics, Inc. $123.3M of $163.0M · 75.6%
- AdvanCell, Inc. $218.3M of $315.0M · 69.3%
- Daniel Spiegelman — Director, South San Francisco, CA
-
Michael Grey — Executive Officer / Director, South San Francisco, CA
2 other raises
- Mirum Pharmaceuticals, Inc. $68.5M of $68.5M · 100.0%
- Plexium, Inc. $60.1M of $60.1M · 100.0%
- Simpson Camilla — Director, South San Francisco, CA
-
Tiba Aynechi — Director, South San Francisco, CA
1 other raise
- Rezo Therapeutics, Inc. $68.1M of $80.1M · 84.9%
- Kirk Ways — Director, South San Francisco, CA
- Samir Gharib — Executive Officer, South San Francisco, CA
- Percival Barretto-Ko — Director, South San Francisco, CA
Placement agents
- H.c. Wainwright & Co., Llc · 0 RE raises
- Leerink Partners Llc · 0 RE raises
- Citizens Jmp Securities, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.